Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

Antiviral Drugs Advisory Committee Charter

To:

Department Committee Management Officer

From:

Associate Commissioner for Special Medical Programs

Through:

Michael F. Ortwerth, Ph.D. _______________
Director Advisory Committee Oversight and Management Staff

Subject:

Notice of Termination

This is to notify you that the Antiviral Drugs Advisory Committee will be officially terminated on February 15, 2015.

Date

Jill Hartzler Warner, J.D.
Associate Commissioner for Special Medical Programs (Acting), FDA

 

Page Last Updated: 03/20/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.